Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2008, Article ID 163902, 8 pages
http://dx.doi.org/10.1155/2008/163902
Research Article

Differential Effects of Leptin on the Invasive Potential of Androgen-Dependent and -Independent Prostate Carcinoma Cells

1Department of Biochemistry, Louisiana State University Health Science Center, New Orleans, LA 70112, USA
2Department of Surgery, University of South Alabama Medical Center, Mobile, AL 36617, USA
3Department of Pathology and Genetics, Louisiana State University Health Science Center, New Orleans, LA 70112, USA
4Stanley S. Scott Cancer Center, Louisiana State University Health Science Center, New Orleans, LA 70112, USA
5Department of Pediatrics, University of South Alabama Medical Center, Mobile, AL 36617, USA
6Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
7Department of Obstetrics and Gynecology, Louisiana State University Health Science Center, New Orleans, LA 70112, USA

Received 25 October 2007; Revised 10 February 2008; Accepted 8 April 2008

Academic Editor: Yan Luo

Copyright © 2008 Dayanand D. Deo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Bub, T. Miyazaki, and Y. Iwamoto, “Adiponectin as a growth inhibitor in prostate cancer cells,” Biochemical and Biophysical Research Communications, vol. 340, no. 4, pp. 1158–1166, 2006. View at Publisher · View at Google Scholar
  2. C. W. Amling, C. J. Kane, R. H. Riffenburgh et al., “Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy,” Urology, vol. 58, no. 5, pp. 723–728, 2001. View at Publisher · View at Google Scholar
  3. Y. Furuya, S. Akimoto, K. Akakura, and H. Ito, “Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan,” International Journal of Urology, vol. 5, no. 2, pp. 134–137, 1998. View at Publisher · View at Google Scholar
  4. C. Rodriguez, A. V. Patel, E. E. Calle, E. J. Jacobs, A. Chao, and M. J. Thun, “Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States,” Cancer Epidemiology Biomarkers & Prevention, vol. 10, no. 4, pp. 345–353, 2001. View at Google Scholar
  5. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar
  6. K. K. Carroll, “Obesity as a risk factor for certain types of cancer,” Lipids, vol. 33, no. 11, pp. 1055–1059, 1998. View at Publisher · View at Google Scholar
  7. M. Sulkowska, J. Golaszewska, A. Wincewicz, M. Koda, M. Baltaziak, and S. Sulkowski, “Leptin—from regulation of fat metabolism to stimulation of breast cancer growth,” Pathology Oncology Research, vol. 12, no. 2, pp. 69–72, 2006. View at Google Scholar
  8. S. S. Strom, X. Wang, C. A. Pettaway et al., “Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy,” Clinical Cancer Research, vol. 11, no. 19 I, pp. 6889–6894, 2005. View at Publisher · View at Google Scholar
  9. L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, and P. Burn, “Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks,” Science, vol. 269, no. 5223, pp. 546–549, 1995. View at Publisher · View at Google Scholar
  10. M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in OB/OB mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Publisher · View at Google Scholar
  11. P. Stattin, S. Söderberg, G. Hallmans et al., “Leptin is associated with increased prostate cancer risk: a nested case-referent study,” Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 1341–1345, 2001. View at Publisher · View at Google Scholar
  12. S. Chang, S. D. Hursting, J. H. Contois et al., “Leptin and prostate cancer,” Prostate, vol. 46, no. 1, pp. 62–67, 2001. View at Publisher · View at Google Scholar
  13. A. W. Hsing, S. Chua Jr., Y.-T. Gao et al., “Prostate cancer risk and serum levels of insulin and leptin: a population-based study,” Journal of the National Cancer Institute, vol. 93, no. 10, pp. 783–789, 2001. View at Publisher · View at Google Scholar
  14. P. Stattin, R. Kaaks, R. Johansson et al., “Plasma leptin is not associated with prostate cancer risk,” Cancer Epidemiology Biomarkers & Prevention, vol. 12, no. 5, pp. 474–475, 2003. View at Google Scholar
  15. S. J. Freedland, L. J. Sokoll, L. A. Mangold et al., “Serum leptin and pathological findings at the time of radical prostatectomy,” Journal of Urology, vol. 173, no. 3, pp. 773–776, 2005. View at Publisher · View at Google Scholar
  16. J. Baillargeon, E. A. Platz, D. P. Rose et al., “Obesity, adipokines, and prostate cancer in a prospective population-based study,” Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 7, pp. 1331–1335, 2006. View at Publisher · View at Google Scholar
  17. P. Somasundar, D. W. McFadden, S. M. Hileman, and L. Vona-Davis, “Leptin is a growth factor in cancer,” Journal of Surgical Research, vol. 116, no. 2, pp. 337–349, 2004. View at Publisher · View at Google Scholar
  18. P. Somasundar, K. A. Frankenberry, H. Skinner et al., “Prostate cancer cell proliferation is influenced by leptin,” Journal of Surgical Research, vol. 118, no. 1, pp. 71–82, 2004. View at Publisher · View at Google Scholar
  19. K. A. Frankenberry, P. Somasundar, D. W. McFadden, and L. C. Vona-Davis, “Leptin induces cell migration and the expression of growth factors in human prostate cancer cells,” The American Journal of Surgery, vol. 188, no. 5, pp. 560–565, 2004. View at Publisher · View at Google Scholar
  20. M. Onuma, J. D. Bub, T. L. Rummel, and Y. Iwamoto, “Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 42660–42667, 2003. View at Publisher · View at Google Scholar
  21. M. R. Sierra-Honigmann, A. K. Nath, C. Murakami et al., “Biological action of leptin as an angiogenic factor,” Science, vol. 281, no. 5383, pp. 1683–1686, 1998. View at Publisher · View at Google Scholar
  22. D. Sharma, N. K. Saxena, P. M. Vertino, and F. A. Anania, “Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways,” Endocrine-Related Cancer, vol. 13, no. 2, pp. 629–640, 2006. View at Publisher · View at Google Scholar
  23. S. Attoub, V. Noe, L. Pirola et al., “Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho-, and Rac-dependent signaling pathways,” The FASEB Journal, vol. 14, no. 14, pp. 2329–2338, 2000. View at Publisher · View at Google Scholar
  24. L. A. Tartaglia, “The leptin receptor,” Journal of Biological Chemistry, vol. 272, no. 10, pp. 6093–6096, 1997. View at Google Scholar
  25. A. S. Banks, S. M. Davis, S. H. Bates, and M. G. Myers Jr., “Activation of downstream signals by the long form of the leptin receptor,” Journal of Biological Chemistry, vol. 275, no. 19, pp. 14563–14572, 2000. View at Publisher · View at Google Scholar
  26. J. N. Ihle, “STATs and MAPKs: obligate or opportunistic partners in signaling,” BioEssays, vol. 18, no. 2, pp. 95–98, 1996. View at Publisher · View at Google Scholar
  27. R. Buettner, L. B. Mora, and R. Jove, “Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention,” Clinical Cancer Research, vol. 8, no. 4, pp. 945–954, 2002. View at Google Scholar
  28. G. Niu, K. H. Shain, M. Huang et al., “Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest,” Cancer Research, vol. 61, no. 8, pp. 3276–3280, 2001. View at Google Scholar
  29. W. Lou, Z. Ni, K. Dyer, D. J. Tweardy, and A. C. Gao, “Interleukin-6 induces prostate cancer cell growth accompanied by activation of STAT3 signaling pathway,” The Prostate, vol. 42, no. 3, pp. 239–242, 2000. View at Publisher · View at Google Scholar
  30. S. K. Katiyar and S. M. Meeran, “Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-κB signaling,” Free Radical Biology and Medicine, vol. 42, no. 2, pp. 299–310, 2007. View at Publisher · View at Google Scholar
  31. A. Hoque, D. Albanes, S. M. Lippman et al., “Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT),” Cancer Causes and Control, vol. 12, no. 7, pp. 627–633, 2001. View at Publisher · View at Google Scholar